Dysglycemia is almost universal in the first weeks after transplantation: insulin resistance is promoted by postsurgical inflammation, and high-dose immunosuppressive medications promote insulin resistance; in addition, patients receiving tacrolimus present an impaired insulin production [154,156]. This evidence concerns the gene INS and Insulin resistance.